Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
European Heart Journal|June 15, 2007
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysisRoberto R Giraldez, José Carlos Nicolau, Ramon Corbalan, et al.
International Journal of Cardiology|May 8, 2010
Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillationHugo Verdejo, Juan Roldan, Lorena Garcia, et al.
Circulation|April 12, 2012
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performanceLakshmi Venkitachalam, Kaijun Wang, Avi Porath, et al.
Current Pharmaceutical Design|January 13, 2017
Novel Therapies Targeting Cardioprotection and RegenerationValeria Garrido, Evelyn Mendoza-Torres, Jaime A Riquelme, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 6, 2019
Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trialAndré M Nicolau, Ramon Corbalan, Jose C Nicolau, et al.
Circulation|September 2, 2008
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38Stephen D Wiviott, Eugene Braunwald, Dominick J Angiolillo, et al.
Circulation|July 22, 2016
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial InfarctionErin A Bohula, Marc P Bonaca, Eugene Braunwald, et al.
European Journal of Preventive Cardiology|August 7, 2013
Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosisJacob A Udell, Ph Gabriel Steg, Benjamin M Scirica, et al.
The American Journal of Medicine|November 2, 2023
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF RegistrySamuel Z Goldhaber, Jean-Pierre Bassand, A John Camm, et al.
Plos One|January 26, 2018
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillationJean-Pierre Bassand, Gabriele Accetta, Wael Al Mahmeed, et al.
Pageof 4